111 related articles for article (PubMed ID: 30204711)
1. Effectiveness of phosphate binders in adult patients with end stage renal disease receiving hemodialysis: a systematic review.
Gasu V; Ashong M; Seferi A; Fitzpatrick A
JBI Database System Rev Implement Rep; 2019 Jan; 17(1):49-73. PubMed ID: 30204711
[TBL] [Abstract][Full Text] [Related]
2. The impact of accessibility to non-calcium-based phosphate binders and calcimimetics on mineral outcomes in patients receiving maintenance hemodialysis: A 10-year retrospective analysis of real-world data.
Disthabanchong S; Kasempin P; Srisuwarn P; Chansomboon P; Buachum N
PLoS One; 2024; 19(5):e0304649. PubMed ID: 38820324
[TBL] [Abstract][Full Text] [Related]
3. Effects of frequent hemodialysis on measures of CKD mineral and bone disorder.
Daugirdas JT; Chertow GM; Larive B; Pierratos A; Greene T; Ayus JC; Kendrick CA; James SH; Miller BW; Schulman G; Salusky IB; Kliger AS;
J Am Soc Nephrol; 2012 Apr; 23(4):727-38. PubMed ID: 22362907
[TBL] [Abstract][Full Text] [Related]
4. Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis.
Wang Y; Xie G; Huang Y; Zhang H; Yang B; Mao Z
PLoS One; 2015; 10(3):e0121376. PubMed ID: 25799184
[TBL] [Abstract][Full Text] [Related]
5. Differences in Phosphate and Parathyroid Hormone Concentrations over the Day among Patients on Hemodialysis.
Ginsberg C; Miller LM; Ofsthun N; Dalrymple LS; Ix JH
J Am Soc Nephrol; 2022 Nov; 33(11):2087-2093. PubMed ID: 36316091
[TBL] [Abstract][Full Text] [Related]
6. Self-Motivation Is Associated With Phosphorus Control in End-Stage Renal Disease.
Umeukeje EM; Merighi JR; Browne T; Victoroff JN; Umanath K; Lewis JB; Ikizler TA; Wallston KA; Cavanaugh K
J Ren Nutr; 2015 Sep; 25(5):433-9. PubMed ID: 25912398
[TBL] [Abstract][Full Text] [Related]
7. Bone Parameters and Risk of Hip and Femur Fractures in Patients on Hemodialysis.
Fishbane S; Hazzan AD; Jhaveri KD; Ma L; Lacson E
Clin J Am Soc Nephrol; 2016 Jun; 11(6):1063-1072. PubMed ID: 27026521
[TBL] [Abstract][Full Text] [Related]
8. Effect of Phosphate-Specific Diet Therapy on Phosphate Levels in Adults Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis.
St-Jules DE; Rozga MR; Handu D; Carrero JJ
Clin J Am Soc Nephrol; 2020 Dec; 16(1):107-120. PubMed ID: 33380474
[TBL] [Abstract][Full Text] [Related]
9. The effect of intradialytic exercise on calcium, phosphorus and parathyroid hormone: a randomized controlled trial.
Tabibi MA; Wilund KR; Salimian N; Nikbakht S; Soleymany M; Roshanaeian Z; Nazemi F; Ahmadi S
BMC Nephrol; 2023 Sep; 24(1):276. PubMed ID: 37730530
[TBL] [Abstract][Full Text] [Related]
10. The impact of low and high dialysate calcium concentrations on cardiovascular disease and death in patients undergoing maintenance hemodialysis: a systematic review and meta-analysis.
Kamei K; Yamada S; Hashimoto K; Konta T; Hamano T; Fukagawa M
Clin Exp Nephrol; 2024 Jun; 28(6):557-570. PubMed ID: 38396314
[TBL] [Abstract][Full Text] [Related]
11. Gender and age differences in KDIGO treatment targets among people on maintenance hemodialysis: Findings from a tertiary hospital in Vietnam.
Pham HV; Tran NV; Thai TT; Tran HTB
Medicine (Baltimore); 2024 Jan; 103(4):e37088. PubMed ID: 38277525
[TBL] [Abstract][Full Text] [Related]
12. Influence of the use of phosphate binders on serum levels of calcium phosphate in patients with chronic kidney disease undergoing hemodialysis: A retrospective and prospective study.
Setiani Agus L; Effendi I; Abdillah S
Saudi Pharm J; 2014 Sep; 22(4):333-7. PubMed ID: 25161377
[TBL] [Abstract][Full Text] [Related]
13. Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy data
.
Coyne DW; Ficociello LH; Parameswaran V; Anderson L; Vemula S; Ofsthun NJ; Mullon C; Maddux FW; Kossmann RJ; Sprague SM
Clin Nephrol; 2017 Aug; 88(8):59-67. PubMed ID: 28587714
[TBL] [Abstract][Full Text] [Related]
14. Effects of iron-based phosphate binders on mortality and cardiovascular events in patients receiving maintenance dialysis.
Tanaka A; Sasaki S; Noma H; Wang J; Onishi Y; Inaguma D
Sci Rep; 2023 Sep; 13(1):16051. PubMed ID: 37749304
[TBL] [Abstract][Full Text] [Related]
15. The hidden and complex relationship between dietary phosphorus and malnutrition in hemodialysis patients with chronic kidney disease.
Milla C; Widodo ; Wardhana TH
Rom J Intern Med; 2024 Mar; 62(1):52-60. PubMed ID: 37991505
[TBL] [Abstract][Full Text] [Related]
16. Serum Phosphorus, Parathyroid Hormone, and Serum Fibroblast Growth Factor-23 in Egyptian Patients Six Months after Undergoing Living-donor Kidney Transplantation.
Kamel MH; Ahmed DH; Mikhael ES; Abdalla MS; Sadek KM; ElNahid MS
Saudi J Kidney Dis Transpl; 2022; 33(3):353-360. PubMed ID: 37843136
[TBL] [Abstract][Full Text] [Related]
17. Phosphate binder pill burden, adherence, and serum phosphorus control among hemodialysis patients converting to sucroferric oxyhydroxide.
Gray K; Ficociello LH; Hunt AE; Mullon C; Brunelli SM
Int J Nephrol Renovasc Dis; 2019; 12():1-8. PubMed ID: 30774412
[TBL] [Abstract][Full Text] [Related]
18. Phosphate Intake and Removal in Predominantly Vegetarian Patients on Twice-Weekly Hemodialysis.
Rao NS; Chandra A; Kulshreshta M; Tiwari P; Saran S; Lohiya A
Indian J Nephrol; 2022; 32(6):582-587. PubMed ID: 36704595
[TBL] [Abstract][Full Text] [Related]
19. Phosphate binders as a cause of hypothyroidism in dialysis patients: practical indications from a review of the literature.
Cataldo E; Columbano V; Nielsen L; Gendrot L; Covella B; Piccoli GB
BMC Nephrol; 2018 Jul; 19(1):155. PubMed ID: 29966512
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Novel Laboratory-Specific Correction Equation for Total Serum Calcium and Its Association With Mortality Among Hemodialysis Patients.
Obi Y; Nguyen DV; Streja E; Rivara MB; Rhee CM; Lau WL; Chen Y; Kovesdy CP; Mehrotra R; Kalantar-Zadeh K
J Bone Miner Res; 2017 Mar; 32(3):549-559. PubMed ID: 27714897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
